February 25, 2023
MICHEL MARTIN, GURJIT KAUR
8-Minute Listen with Transcript
Washington state Attorney General Bob Ferguson says he is suing the Food and Drug Administration because the restrictions on the abortion drug mifepristone are "entirely unreasonable and not medically necessary."
Ferguson, who spoke with NPR's All Things Considered on Saturday, is one of a dozen Democratic attorneys general who filed a lawsuit accusing the federal agency of excessively regulating the drug.
Abortion advice should be as safe as abortion itself
By Tracey Allyson Wilkinson
January 31, 2020
It’s completely reasonable for people to disagree about the morality of abortion. It’s completely unreasonable — and unethical — for medical professionals and those masquerading as them to give potentially life-endangering misinformation about it.
Abortion by medication has been available in the United States since 2000, when it was approved by the Food and Drug Administration. The regimen consists of two pills taken 24 to 48 hours apart. The first pill, mifepristone, blocks the hormone progesterone, which is required for pregnancy. The second pill, misoprostol, causes the uterus to empty. This two-pill approach is currently used in 39% of all abortions in the U.S., a proportion that has been increasing over time.
Continued: https://www.statnews.com/2020/01/31/abortion-advice-should-be-as-safe-as-abortion-itself/
Mail-Order Abortion Pills Shouldn’t Be More Regulated Than Viagra
By: Robin Marty
November 18, 2018
With insurance costs skyrocketing, medical companies are doing everything they can to make health care more affordable — like reducing resources needed for minor medical interactions. Technology is helping to cut costs, with telemed appointments and drug delivery services replacing traditional doctors visits and pharmacy stops.
And that low-cost and easy distribution is coming to reproductive health care, too.
Continued: https://www.care2.com/causes/mail-order-abortion-pills-shouldnt-be-more-regulated-than-viagra.html
Facebook
Google+
Twitter
LinkedIn